Aspirin Use in Patients Aged 80 years and over in Turkey: Snapshot of Results from the ASSOS Study
![Thumbnail](/xmlui/bitstream/handle/20.500.12809/10958/%c3%87elik.pdf.jpg?sequence=4&isAllowed=y)
View/ Open
Date
2023Author
Memiç Sancar, KadriyeÇelik, Oğuzhan
Çil, Cem
Başaran, Özcan
Demirci, Erkan
Ozan Tanık, Veysel
Yetim, Mücahit
Metadata
Show full item recordCitation
Kadriye Memiç Sancar, Oğuzhan Çelik, Cem Çil, Özcan Başaran, Erkan Demirci, Veysel Ozan Tanık, Mucahit Yetim, Osman Karaarslan, Lütfü Bekar, Tolga Doğan, Mubariz Murat Resulzade, Çağlar Kaya, Volkan Doğan, Murat Biteker. Aspirin Use in Patients Aged 80 years and over in Turkey: Snapshot of Results from the ASSOS Study. anatol j fm. 2022; 5(2): 79-84Abstract
Objectives: Acetylsalicylic acid (aspirin) is commonly used with various indications, especially in the elderly population. This study aims to evaluate the prevalence of polypharmacy and aspirin use in patients aged ≥80 years. Methods: The ASSOS trial is a cross-sectional, national registry study. This nonrandomized study was conducted by 30 cardiologists in 14 cities on the elderly (over the age of 80 years) who used aspirin (80–325 mg). Polypharmacy is described as an intake of five or more medicines daily. Results: A total of 309 patients were included in the study, and 146 (47.2%) of them were females. Aspirin treatment for primary prevention (PP) was reported to be given to 101 (32.7%) patients, and polypharmacy was detected in 198 (64.1%) patients. Major gastrointestinal bleeding was reported in 7 (3.5%) patients in the polypharmacy group and 0 (0.0%) patients in the without polypharmacy group (p=0.043). Minor bleeding was reported in 58 (29.3%) patients in the polypharmacy group and in 8 (7.2%) patients in the group without polypharmacy (p[removed]